Announcements Trials
Browse Landscape

Phase

Phase 2 31Phase 1 16Phase 1/2 7Phase 3 5Phase 2/3 3Phase NA 1Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasm, Residual 2Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 11Idarubicin 6fludarabine 5venetoclax 4Granulocyte Colony-Stimulating Factor 4Azacitidine 4posaconazole 3fludarabine phosphate 2Micafungin 2Gemtuzumab 2Filgrastim 2Decitabine 2Daunorubicin 2ruxolitinib 1olutasidenib 1molgramostim 1eltrombopag 1aldesleukin 1aclacinomycins 1Transplantation, Homologous 1Topotecan 1Tobacco Use Cessation Devices 1Thiotepa 1Stem Cell Transplantation 1Safety 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Myeloid, Acute × Stem Cell Transplantation × Clear all
NCT00199147 2005-10-26

Efficacy of G-CSF-Priming in Elderly AML Patients

Johann Wolfgang Goethe University Hospital

Phase 4 Unknown
250 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡